Aleris Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Kolkata, West Bengal, India, established in 2021.
2021 Kolkata, West Bengal, India Active
Last Updated:
Access Report
About Aleris Pharmaceuticals Limited

Aleris Pharmaceuticals Limited, a active public limited company, was established on 13 May 2021 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24304WB2021PLC245141. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.50 M.

Its leadership includes Anand Kumar Parmanandka (Director), Rubi Mukhopadhyay (Director), Biswajit Pan (Director). It holds ₹20.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 55,B.R.B. Basu Road, Kolkata, West Bengal, 700001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304WB2021PLC245141

  • Registration Number

    245141

  • Incorporation Date

    13 May 2021

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 4 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 20.00 Cr
  • Revenue Growth **** %
  • Net Worth 0.48%
  • Total Assets **** 2.86%
Company report

Aleris Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aleris Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Aleris Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Anand Kumar Parmanandka Director 13 May 2021 Current
Rubi Mukhopadhyay Director 13 May 2021 Current
Biswajit Pan Director 13 May 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aleris Pharmaceuticals.

Aleris Pharmaceuticals Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 0.48%.

Aleris Pharmaceuticals revenue growth over time
Aleris Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 2.86%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
 0.48%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aleris Pharmaceuticals?

In 2022, Aleris Pharmaceuticals had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹200,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 20.00 Cr
Latest Charge Details
Date Lender Amount Status
11 Nov 2025 Others ₹20.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Aleris Pharmaceuticals?

Aleris Pharmaceuticals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aleris Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aleris Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aleris Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge with Others amounted to Rs. 200.00 M with Charge ID 101189765 was registered on 11 Nov 2025. was documented.

  • Annual General Meeting

    Progress on Aleris Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Aleris Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata. was recorded as a recent event.

  • Director Appointment

    The activity Anand Kumar Parmanandka was appointed as a Director was appointed as a Director on 13 May 2021 & has been associated with this company since 4 years 9 months . was completed.

  • Director Appointment

    The activity Rubi Mukhopadhyay was appointed as a Director was appointed as a Director on 13 May 2021 & has been associated with this company since 4 years 9 months . was completed.

  • Director Appointment

    Progress on Biswajit Pan was appointed as a Director was appointed as a Director on 13 May 2021 & has been associated with this company since 4 years 9 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aleris Pharmaceuticals Limited?

The CIN of Aleris Pharmaceuticals Limited is U24304WB2021PLC245141.

Where is Aleris Pharmaceuticals Limited headquartered?

Aleris Pharmaceuticals Limited is headquartered at 55,B.R.B. Basu Road, Kolkata, West Bengal, 700001.

When was Aleris Pharmaceuticals Limited incorporated?

Aleris Pharmaceuticals Limited was incorporated on 13 May 2021.

Who are the current directors of Aleris Pharmaceuticals Limited?

The current directors of Aleris Pharmaceuticals Limited are

What is the primary industry of Aleris Pharmaceuticals Limited?

The primary industry of Aleris Pharmaceuticals Limited is Manufacturing.

Is Aleris Pharmaceuticals Limited a listed company?

Aleris Pharmaceuticals Limited is unlisted.

What is the capital structure of Aleris Pharmaceuticals Limited?

The authorized capital of Aleris Pharmaceuticals Limited is ₹5.00 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available